RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2018

Oct 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2018-10-15

Reporting Person: Stewart Murray (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-15	Employee Stock Option (right to buy)	$26.54	A	100000	Acquired	2028-10-14	Common Stock (100000)	Direct

Footnotes

F1: The option vests as follows: (1) 25% on October 15, 2019, and (2) the remaining 75% in 12 equal quarterly installments.